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OBJECTIVE—Gluteo-femoral, in contrast to abdominal, fat
accumulation appears protective against diabetes and cardiovas-
cular disease. Our objective was to test the hypothesis that this
reﬂects differences in the ability of the two depots to sequester
fatty acids, with gluteo-femoral fat acting as a longer-term “sink.”
RESEARCH DESIGN AND METHODS—A total of 12 healthy
volunteers were studied after an overnight fast and after inges-
tion of a mixed meal. Blood samples were taken from veins
draining subcutaneous femoral and abdominal fat and compared
with arterialized blood samples. Stable isotope-labeled fatty
acids were used to trace speciﬁc lipid fractions. In 36 subjects,
adipose tissue blood ﬂow in the two depots was monitored
with
133Xe.
RESULTS—Blood ﬂow increased in response to the meal in
both depots, and these responses were correlated (rs  0.44, P 
0.01). Nonesteriﬁed fatty acid (NEFA) release was suppressed
after the meal in both depots; it was lower in femoral fat than in
abdominal fat (P  0.01). Plasma triacylglycerol (TG) extraction
by femoral fat was also lower than that by abdominal fat (P 
0.05). Isotopic tracers showed that the difference was in chylo-
micron-TG extraction. VLDL-TG extraction and direct NEFA
uptake were similar in the two depots.
CONCLUSIONS—Femoral fat shows lower metabolic ﬂuxes
than subcutaneous abdominal fat, but differs in its relative
preference for extracting fatty acids directly from the plasma
NEFA and VLDL-TG pools compared with chylomicron-TG.
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O
besity is associated with increased risk of cor-
onary heart disease and type 2 diabetes. The
distribution of body fat is an important factor in
this relationship. The ratio of abdominal to
lower-body (gluteo-femoral) fat accumulation, measured
by the waist-to-hip ratio, is a major determinant of adverse
metabolic consequences and mortality, independent of the
degree of obesity (1,2). In recent years, it has become clear
that not only is lower-body fat less harmful than abdomi-
nal fat, but it actually provides protection against coronary
heart disease and type 2 diabetes (rev. in 3).
The reason for the different relationships of these two
major fat depots to metabolic health is not clear. On the
basis of in vitro observations, it has been postulated that
lipolysis, and hence delivery of nonesteriﬁed fatty acids
(NEFAs) into the systemic circulation, is greater in ab-
dominal adipose tissue (4,5) and less readily suppressed
by insulin (6). These arguments have been extended to
visceral fat, which has a high rate of lipolysis in vitro (7,8),
and in many studies is the depot most closely associated
with metabolic risk (9,10). However, it is evident that this
explanation alone cannot be sufﬁcient, since any fat depot
with a high rate of lipolysis should disappear unless fat
mobilization is matched by a high rate of fatty acid uptake,
i.e., a high rate of turnover (11).
The most consistent argument for the protective prop-
erties of lower-body fat, viewed in that light, is that
lower-body fat depots provide a long-term energy store
and hence act as a “metabolic sink” for excess fat,
protecting other tissues from excessive exposure to fatty
acids (12; rev. in 3). In support of this hypothesis is the fact
that the gluteo-femoral depots are lost more slowly than
abdominal depots during an energy deﬁcit (13–15). Direct
measurements of fat turnover after oral administration of
radio-labeled fat show faster turnover in subcutaneous
abdominal than femoral fat (16). Several studies have been
made of the short-term adipose tissue uptake of radio-
labeled dietary fat. In lean people, short-term uptake of
meal-derived fatty acids is greater in subcutaneous abdom-
inal than in femoral adipose tissue, because of greater
efﬁciency of uptake and greater adipose tissue mass
(17,18). However, women with lower-body obesity store
more dietary fat over 24 h in the lower body (gluteal fat
depot) than women with upper-body obesity or obese men
(15). In addition, lean women, as compared with men,
preferentially store fat in their lower-body adipose tissue
when fed a high-fat high-calorie meal (19).
Little is known of the physiological and metabolic
responses at the tissue level that lead to these differences
in handling of excess fat. For instance, an increase in
adipose tissue blood ﬂow (ATBF) after meal intake (20)
may have a role in presenting substrate to lipoprotein
lipase (LPL) in adipose tissue capillaries for uptake (21)
and delivering signals such as insulin to promote fat
storage. Studies of the regulation of ATBF in different
depots have given divergent results (reviewed in DISCUS-
SION). LPL activity measured in biopsies in the fed state is
correlated with meal fatty acid uptake and is greater in
femoral fat than in abdominal fat (19,22), but physiological
measurements of LPL action in vivo, which would include
the effects of ATBF, have not been made.
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pose tissue as a metabolic sink might be most apparent in
the fed state and would be reﬂected in a greater ability of
femoral than abdominal adipose tissue to entrap dietary
fatty acids. The metabolic physiology of the subcutaneous
abdominal fat depot has been investigated extensively
using measurements of ATBF in conjunction with arterio-
venous difference measurements (23). Recently, we de-
scribed a similar technique for studying the metabolic
physiology of the subcutaneous femoral adipose depot
(24). Here we report the ﬁrst direct comparisons of the
physiological and metabolic responses of the two adipose
depots to meal ingestion.
RESEARCH DESIGN AND METHODS
Participants and protocol. We studied ATBF responses to meal ingestion in
36 healthy nonobese subjects (18 males and 18 females comparable for age
and BMI). In a subgroup of 12 of these volunteers (eight males), we conducted
detailed studies of metabolic physiology by measurement of arterio-venous
differences across the two depots.
Volunteers were recruited from the greater Oxford community by adver-
tisement or from the Oxford BioBank (25). The protocol was approved by the
Oxfordshire Research Ethics Committee, and all participants gave written
informed consent. None of the subjects was taking medication known to affect
lipid metabolism and all were normoglycemic. They were asked to consume a
corn-free diet for 48 h before the study and to refrain from strenuous exercise
and alcohol for 24 h before the study. They attended the Oxford Centre for
Diabetes, Endocrinology and Metabolism Clinical Research Unit, having
fasted from 10:00 P.M. the previous night.
ATBF was measured in subcutaneous abdominal and femoral depots with
the
133Xe washout method, as described previously (26), in the fasting state
and after the ingestion of a mixed meal. The mixed meal contained 40 g fat as
olive oil in the form of a chocolate-ﬂavored emulsion with 400 mg emulsiﬁer
and ﬂavorings and 40 g carbohydrate as Rice Krispies (Kellogg, Manchester,
U.K.) with skimmed milk (200 g) (27).
In the “metabolic study” subgroup, arterio-venous differences were mea-
sured across abdominal and femoral adipose tissue. A superﬁcial epigastric
vein draining subcutaneous abdominal fat (28), a branch of the great saphe-
nous vein draining femoral fat (24), and an arterialized dorsal hand vein (with
the hand kept in a warming box at 60°C) were cannulated. The cannulae were
kept patent with 0.9% saline. We used plasma creatinine concentrations as an
indication of contamination by muscle venous blood (24).
Stable isotope-labeled fatty acids were used to trace different lipid pools as
described previously (29). A constant infusion of [
2H2]palmitate (CK Gas
Products, Hampshire, U.K.) was given intravenously (0.01 mol  kg
1  min
1)
in 400 ml human albumin (4.5%) throughout the study to trace endogenous
fatty acid metabolism and the VLDL-triacylglycerol (TG) pool (produced in the
liver after hepatic uptake of labeled plasma NEFAs). [U
13C]palmitate (100 mg)
was added to the fat emulsion as part of the mixed meal (29) to trace
exogenous (dietary) fatty acid metabolism.
In the metabolic study subgroup, blood samples were taken simultaneously
from all three sites at baseline (30 and 0 min) and at 30, 60, 90, 120, 180, 240,
300, and 360 min after the meal. Skin temperatures were measured throughout
the study at regular intervals. Abdominal and thigh skin temperatures re-
mained relatively constant, and no differences between sites were noted.
Analytical methods. Blood samples were drawn into heparinized syringes
(Sarstedt, Leicester, U.K.), and plasma was prepared rapidly at 4°C. Glucose
concentrations were measured immediately, and remaining samples were
frozen before analysis. Plasma TG, NEFAs, glucose, and creatinine were
analyzed enzymatically using commercially available kits on an ILAB600 or
ILAB650 clinical analyzer (Instrumentation Laboratory U.K., Warrington,
U.K.), and insulin was measured by radioimmunoassay (Millipore, Watford,
U.K.).
Chylomicron (Sf 400) and VLDL (Sf 20–400) fractions were prepared
from plasma by sequential ﬂotation in the ultracentrifuge as described
previously (29). TG concentrations were measured enzymatically as above.
Lipid fractions (NEFA and TG) were separated, and fatty acid composition
and tracer enrichment were analyzed by gas chromatography and mass
spectrometry as described previously (29). Enrichments were converted to
tracer-to-tracee ratios.
Calculations and statistics. ATBF was calculated from the washout of
133Xe
assuming a partition coefﬁcient of 10 ml/g for both depots (30). Although this
may not be accurate for each individual, the emphasis in this study was on
changes induced by feeding within depots and on correlations between the
depots. There is no consistent difference in partition coefﬁcient between
subcutaneous abdominal and thigh adipose tissue (30,31). Baseline ATBF was
taken as the average at time 30 and 0 min. Peak ATBF was calculated as the
greatest mean of three adjacent points after the meal (20). The ATBF response
to the meal was calculated as peak minus baseline.
Metabolic calculations were made as described previously (29) and are
described in RESULTS. We calculated chylomicron- and VLDL-TG extraction
across the tissues directly, based on the rates of extraction of [
13C]palmitate
in TG and [
2H2]palmitate in TG, respectively. They were multiplied by the
appropriate tracer-to-tracee ratio and percentage of palmitate in TG. Net
transcapillary ﬂux of fatty acids across adipose tissue was calculated as the
difference between total arterialized and total venous fatty acids [(TG  3 
NEFA)arterial  (TG  3  NEFA)venous] (32). It represents the net ﬂux of fatty
acids between adipocytes and capillaries. We applied the same calculation to
isotopically labeled fatty acids to represent the handling of all fatty acids (TG
and NEFA) arising from chylomicron and VLDL fractions.
Data were analyzed using SPSS Statistics, version 17.0. Repeated measures
(RM)-ANOVA with time and site as within-subject factors was used to identify
time and site effects, and sex was used as a between-subject factor to identify
sex effects. Spearman rank correlation coefﬁcient (rs) was used to test for
associations. Data are presented as mean  SE unless otherwise stated.
RESULTS
Adipose tissue blood ﬂow. Characteristics of the partic-
ipants in whom ATBF was studied are given in Table 1.
Age and BMI of the male and female participants were
similar, but as expected, the females had greater body fat
content.
There was no difference in fasting ATBF between sub-
cutaneous abdominal and femoral depots (P  0.64). After
the mixed meal, ATBF increased in both depots (Fig. 1A),
with signiﬁcant main effects of time (P  0.001) and site
(P  0.003) by RM-ANOVA. The peak was on average at 60
min and was higher in the abdominal than the femoral
depot (P  0.01). There were no sex differences in fasting
or in postprandial abdominal or femoral ATBF (not
shown).
In the whole group, there was a positive relationship
between fasting and peak ATBF within both abdominal
and femoral AT depots (rs  0.67 and rs  0.64, respec-
tively, each P  0.001). Comparing the two depots, there
was no correlation between fasting ATBF in the abdominal
and femoral depots (rs  0.15, P  0.38). However, peak
abdominal and peak femoral ATBF were positively corre-
lated (rs  0.53, P  0.001), and the blood ﬂow response
(peak  baseline) in abdominal adipose tissue was corre-
lated with the blood ﬂow response in femoral adipose
tissue (rs  0.44, P  0.01).
Peak postprandial ATBF and, to a lesser extent, the
ATBF response were negatively related to measures of
adiposity. These associations were generally weaker for
femoral than for abdominal ATBF (e.g., peak ATBF vs.
BMI, rs  0.47, P  0.01; rs  0.36, P  0.03, for
abdominal and femoral fat, respectively). These relation-
ships also existed for waist and hip circumference (versus
peak abdominal ATBF, rs  0.44, P  0.01; rs  0.43,
P  0.01, respectively). There was no consistent pattern of
TABLE 1
Characteristics of participants in the ATBF study
Men Women
n 18 18
Age (years) 34.0  10.8 36.6  13.2
BMI (kg/m
2) 24.4  2.8 23.5  2.7
Body fat (%) 16.6  1.4 28.1  1.4*
Waist-to-hip ratio 0.88  0.08 0.78  0.01
Data are means  SD or n.* P  0.001.
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waist or hip circumference in men compared with women.
It should be noted that waist and hip circumferences
were themselves positively correlated within each sex
(males, rs  0.68, P  0.002; females, rs  0.57, P  0.01)
and over the whole group (rs  0.59, P  0.001).
Metabolic study: systemic concentrations. Character-
istics of the participants in the metabolic substudy are
shown in Table 2.
ATBF in this subgroup followed a similar pattern to that
in the larger group (Fig. 1A). Systemic concentrations of
glucose, insulin, and TG rose after the meal, whereas those
of NEFAs fell (Fig. 1B–D). There was consistent extraction
of glucose and TG across both depots and release of NEFA
(raw concentrations are shown in Fig. 1C).
Creatinine concentrations were similar in the three
sampling sites (Fig. 2A), although there was a small but
signiﬁcant site effect. Mean concentrations averaged over
the experimental period were as follows: arterial 67.9 
3.8 mol/l, abdominal adipose venous 66.7  3.7 mol/l,
and femoral adipose venous 69.0  3.8 mol/l. (For
comparison, concentrations in a vein draining skeletal
muscle are typically 20% greater than in arterial blood
[24].)
Adipose tissue substrate ﬂuxes. Glucose uptake was
identical in the two depots in the fasting state and in-
creased in both depots after the meal (Fig. 2B), with an
early peak but otherwise mirroring arterialized glucose
concentrations. NEFA release (Fig. 2C) tended to be lower
in the fasting state in femoral compared with subcutane-
ous abdominal adipose tissue (P  0.1). It suppressed
similarly after the meal in both depots, but was signiﬁ-
cantly lower in femoral than in abdominal adipose tissue.
TG extraction (Fig. 2D) was similar in the two depots in
the fasted state. It increased in both after the meal, but
tended to be lower in the femoral than the subcutaneous
abdominal depot.
For each of these parameters, sex effects were investi-
gated by including sex as a between-subjects factor in the
RM-ANOVA. For glucose uptake, there was a time  sex
interaction (P  0.03) reﬂecting a greater peak value in the
men in both depots. This was not seen for either NEFA
release or TG extraction.
Measures of net fatty acid retention in the two adipose
tissue depots are shown in Fig. 3. Transcapillary fatty acid
ﬂux (Fig. 3A), reﬂecting the net movement of fatty acids in
and out of adipocytes (32), was negative (fat mobilization)
in the fasting state and became positive (fat storage) after
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FIG. 1. ATBF and systemic concentrations in the fasting and postprandial states. A: ATBF. n  36. B: Arterialized plasma glucose and plasma
insulin. C: Plasma NEFAs. D: Arterialized plasma TG. For B, C, and D, n  12.
TABLE 2
Characteristics of participants in the metabolic study
n (M/F) 12 (8/4)
Age (years) 32.3  11.3
BMI (kg/m
2) 24.2  3.1
Body fat (%) 20.4  8.3
Waist-to-hip ratio 0.85  0.07
Data are means  SD or n. These participants were a subset of the
36 participants in the ATBF study.
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less negative in femoral than in subcutaneous abdominal
adipose tissue (P  0.06); after the meal, it responded less,
with a signiﬁcant time  site interaction (P  0.02).
Fractional re-esteriﬁcation of fatty acids within adipose
tissue was calculated from the mass balances of NEFA and
glycerol (Fig. 3B). In the fasting state, it was similar in the
two depots and correlated between them (rs  0.60, P 
0.04, Fig. 3C). It increased in both depots after the meal
and remained higher in the femoral than the subcutaneous
abdominal tissue in the late postprandial period. Average
values over the postprandial period were also highly
correlated between the two depots (rs  0.93, P  0.001,
Fig. 3D). Neither sex nor insulin concentrations were
involved in these close relationships between the two
depots, nor were BMI and percentage body fat.
Whole-depot responses were estimated using depot fat
masses measured by dual-energy X-ray absorptiometry in
seven volunteers. These data are shown in supplementary
Table 1 in the online appendix (available at http://diabetes.
diabetesjournals.org/cgi/content/full/db10-0678/DC1) and
conﬁrm the greater substrate ﬂuxes in abdominal fat on a
whole-depot basis.
Tracer studies. The pathways of fat uptake were further
investigated using the tracer fatty acids, [
13C]palmitate
incorporated into the dietary fat, and [
2H2]palmitate,
which was infused to label both the plasma NEFA and the
newly synthesized VLDL-TG pools.
Both adipose depots extracted [
13C]TG-palmitate (rep-
resenting chylomicron-TG), with a peak rate at 120–180
min and, similar to total plasma TG extraction (Fig. 2D),
the rate was lower in femoral than in subcutaneous
abdominal adipose tissue (P  0.02). Chylomicron-TG
extraction calculated based on these data are shown in
Fig. 4A. It was also lower in femoral than in subcutaneous
abdominal adipose tissue. Both adipose depots demon-
strated “spillover” of chylomicron-derived fatty acids, as-
sessed by the appearance of
13C-labeled palmitate in the
venous plasma (33) (Fig. 4B). This was lower in the
femoral than the subcutaneous abdominal adipose depot,
reﬂecting lower extraction of
13C-labeled TG as above.
Fractional spillover of
13C-labeled fatty acids (i.e., the
proportion of those
13C-labeled fatty acids released by LPL
that enter the plasma NEFA pool) was therefore not
different between the depots (P  0.65).
In contrast, handling of [
2H2]palmitate, the infused
tracer marking both the plasma NEFA pool and newly
synthesized VLDL-TG, was not different between the de-
pots. Directly measured [
2H2]TG-palmitate extraction was
similar in the two depots, as was VLDL-TG extraction
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FIG. 2. Tissue-speciﬁc responses in the fasting and postprandial states. A: Plasma creatinine. B: Adipose tissue glucose uptake. C: Adipose tissue
NEFA release. D: Adipose tissue TG extraction. RM-ANOVA shows the following: creatinine, main effects of site (P  0.004) and time (P  0.007);
glucose uptake, main effect of time (P  0.01), no effect of site or time  site interaction; NEFA release, main effects of time and of site (P <
0.01) with time  site interaction (P  0.02); TG extraction, main effects of time (P  0.01) and site (P  0.052) (interaction, P  0.07).
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eriﬁed [
2H2]palmitate was analyzed speciﬁcally as an indi-
cation of the pathway of “direct NEFA uptake.” In both
depots, the ﬂux of nonesteriﬁed [
2H2]palmitate (Fig. 4D)
changed between release in the fasting and late postpran-
dial states (this represents spillover from VLDL-TG) and
uptake in the early postprandial period (reﬂecting the
direct NEFA uptake pathway). Handling of nonesteriﬁed
[
2H2]palmitate was not different between the depots. There
was a correlation between fasting values (net release of
esteriﬁed [
2H2]palmitate representing spillover from
VLDL-TG) in the two depots (rs  0.66, P  0.03), although
not after feeding.
Net uptake of fatty acids is a combination of TG
extraction and entrapment (the complement of spillover)
and is measured by the net transcapillary ﬂux. The move-
ment of the two fatty acid tracers ([
13C]- and
[
2H2]palmitate) was therefore examined in this way (Fig.
5). The transcapillary ﬂux of [
13C]palmitate (Fig. 5A),
representing the uptake of dietary fatty acids from chylo-
micron-TG, was signiﬁcantly greater in subcutaneous ab-
dominal than in femoral adipose tissue. In contrast, the net
transcapillary ﬂux of [
2H2]palmitate, which represents
mainly the uptake of fatty acids from VLDL-TG, with a
smaller component of direct plasma NEFA uptake, was
not different between the two depots (Fig. 5B). The ratio of
[
13C]palmitate to [
2H2]palmitate transcapillary ﬂux was
calculated as an index of this preferential relative removal
of [
2H2]palmitate by femoral fat and showed a site  time
interaction (P  0.054).
DISCUSSION
We directly compared subcutaneous abdominal and fem-
oral adipose tissue in the fasting and fed states. There
were clear similarities between the two depots: ATBF
increased in response to meal ingestion, and the pathways
of fat deposition were qualitatively similar between the
two depots. The depots differed in one respect: whereas
chylomicron-TG was clearly the favored source for post-
prandial fat deposition in subcutaneous abdominal fat, the
femoral depot discriminated less against VLDL-TG.
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studied as has that in the abdominal depot. In postabsorp-
tive lean subjects, subcutaneous abdominal ATBF has
been reported to be higher than femoral ATBF (34,35) and
gluteal ATBF (36), whereas other studies have reported
that abdominal and femoral ATBF are similar in lean
individuals (37,38). In obese subjects, abdominal and
femoral ATBF were similar (34,38), but after 7 days of
fasting, abdominal ATBF increased, whereas femoral
ATBF did not (34). In the present study, we showed
qualitatively similar responses in the two depots to meal
ingestion. This has been shown previously after a carbo-
hydrate-rich meal or a glucose load (37,38).
Of special interest, we and others have shown previ-
ously that the responsiveness of abdominal ATBF to meal
ingestion varies markedly from person to person
(20,38,39), partly depending on obesity status or insulin
sensitivity. Jansson et al. (38) have shown that this respon-
siveness is also lost in obesity in the femoral fat depot.
Here we show for the ﬁrst time that the responsiveness of
the two depots is correlated over a relatively normal BMI
range. Although we did not assess sympathoadrenal re-
sponses in this study, the postprandial increase in ATBF is
largely mediated via -adrenergic receptors (37,40), and it
may be that the sympathoadrenal response to meal intake
varies between individuals and is one reason for this
similarity in the two depots.
Ours is not the ﬁrst study to examine lower-body
adipose depots by measurements of arterio-venous differ-
ences. Indeed, one of the earliest studies of NEFA metab-
olism used saphenous vein measurements to demonstrate
NEFA release from subcutaneous adipose tissue and
showed that it was suppressed after glucose and insulin
administration (41). More recently, Tan et al. (36) cannu-
lated veins draining gluteal fat and showed that the gluteal
adipose depot is distinctly less metabolically active than
the abdominal depot in the fasting state. However, the
gluteal depot may have speciﬁc properties. In a series of
studies by Jensen and colleagues, lower-body fat metabo-
lism has been studied by sampling from the femoral vein,
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FIG. 4. Tracer-based measurements of chylomicron- and VLDL-TG extraction by the two adipose tissue depots. A: Extraction of chylomicron-TG.
B: Net ﬂux (expressed as release) of nonesteriﬁed [U
13C]palmitate from adipose tissue (“spillover”). C: Extraction of VLDL-TG. D: Net ﬂux
(expressed as release) of nonesteriﬁed [
2H2]palmitate across adipose tissue (negative values therefore show net uptake). RM-ANOVA shows the
following: chylomicron-TG extraction, main effects of time (P  0.03) and site (P  0.03); [U
13C]palmitate ﬂux, main effects of site (P  0.025)
and time (P < 0.001); VLDL-TG extraction, no signiﬁcant effects; [
2H2]palmitate ﬂux, main effect of time (P  0.02) with no effect of site (P 
0.20) or time  site interaction.
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tion with appropriate tracer measurements (rev. in 42).
Upper-body subcutaneous adipose tissue shows greater
rates of lipolysis than lower-body fat (when expressed as
NEFA release per kilogram fat) in lean males and females
in the postabsorptive state (43). After mixed-meal inges-
tion, leg NEFA release is more readily suppressed than
upper-body subcutaneous fat in lean subjects—more so in
females than males (43) and especially so in upper-body
obese women (44).
We also found that femoral fat was less metabolically
active than abdominal fat in many, but not all, respects.
For instance, glucose uptake was similar in the two
depots, which is consistent with other studies. In lean
males, glucose uptake, as measured by positron emission
tomography using 2-ﬂuoro-2-deoxy-D-glucose, was similar
in abdominal and femoral AT depots during normoglyce-
mic hyperinsulinemia (45). Glucose uptake 4 h after inges-
tion of 100 g glucose containing a radio-tracer showed no
difference between abdominal and femoral sites (46).
Some metabolic parameters were correlated between
the two depots, but some were not. Particularly striking
was the strong relationship between re-esteriﬁcation (i.e.,
storage) of fatty acids in the two depots in the fed state.
This did not depend on relationships with insulin concen-
trations, nor with sex or adiposity, and may reﬂect a
fundamental individual characteristic of adipose tissue.
The pathway of “direct NEFA uptake” has been revealed
recently from in vivo studies (29,35). Because NEFAs arise
from adipose tissue, it has been suggested that this is a
means of redistributing fatty acids between adipose de-
pots (35). In our studies, direct NEFA uptake was clearly
seen, and quantitatively similar, in both depots in the
postprandial state, implying that there was not a net
movement of fatty acids by this route from one depot to
another. However, it may be that subtle differences occur-
ring day after day can lead to signiﬁcant fat redistribution,
as suggested by Shadid et al. (35). A related potential
mechanism for body fat redistribution, only recently stud-
ied, is the preferential delivery of VLDL-TG toward partic-
ular fat depots. VLDL-TG represents another form of
recycling of adipose tissue–derived fatty acids as well as
dietary fatty acids that have passed through the liver. In a
recent study, women with lower-body obesity channeled a
larger proportion of ex vivo–labeled VLDL-TG toward
deposition in subcutaneous femoral tissue compared with
abdominal adipose tissue in the postabsorptive state (47).
Furthermore, the more femoral fat there is, the greater the
efﬁciency of VLDL-TG uptake into that depot (48). This
relationship between femoral fat mass and increased
femoral fat uptake has also been seen in studies of meal fat
deposition (49). Our data, looking for the ﬁrst time at the
postprandial state, suggest that the femoral depot differs
from the subcutaneous abdominal in discriminating less
between chylomicron- and VLDL-TG. Whereas the former
was by far the major substrate for net fat uptake in the
postprandial period in subcutaneous abdominal fat, this
distinction was not found in the femoral depot.
In summary, we found that the femoral adipose depot
was generally rather less active in terms of blood ﬂow and
fatty acid ﬂuxes than the subcutaneous abdominal depot,
when comparing responses in the fasting to feeding tran-
sition after a single meal. This is in contrast to our
expectations of seeing more avid entrapment of dietary fat
in the femoral depot, in keeping with its proposed role as
a metabolic sink. However, it is important to distinguish
short-term “transmembrane fatty acid ﬂux” from longer-
term net changes in fat mass (11). Our ﬁnding that the two
depots were quantitatively similar in terms of removal of
VLDL-TG and direct uptake of NEFAs suggests an inter-
pretation that the femoral depot may act as a sink for fatty
acids not immediately removed by more active depots
such as the subcutaneous abdominal depot. In normal
daily life in a state of energy balance, fat depots are neither
expanding nor contracting. It could be that in a state of
chronic positive energy balance, the femoral depot would,
at least in some people, become more active in entrapment
of excess dietary fat and would thus protect nonadipose
tissues from ectopic fat deposition. Our studies were
conducted with a single meal only. It would be important
now to test this hypothesis with studies over a 24-h period
(50) involving three test meals.
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FIG. 5. Net transcapillary ﬂux of labeled palmitic acid in the fasting and postprandial states. Units are nmol  100 g
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via the LPL pathway, and direct uptake and spillover as shown in Fig. 4D. RM-ANOVA shows the following: net transcapillary ﬂux of
[U
13C]palmitate, main effects of site (P  0.042) and time (P < 0.001); net transcapillary ﬂux of [
2H2]palmitate, main effect of time (P  0.012),
no effect of site (P  0.67) or time  site interaction (P  0.13).
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